Evidence map›Paper›PMID 31746912›Full record

ArticleNanoscale2019

Predicting in situ nanoparticle behavior using multiple particle tracking and artificial neural networks.

Chad Curtis, Mike McKenna, Ceza Pontes, Dorsa Toghani, Alex Choe, Elizabeth Nance

Abstract read
In one paragraph

Article in Nanoscale, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Passive and Active Microrheology for Biomedical Systems.Frontiers in bioengineering and biotechnology · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chad CurtisDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195, USA. eanance@uw.edu.
Mike McKenna
Ceza Pontes
Dorsa Toghani
Alex Choe
Elizabeth Nance

Funding

Quantitative 3D imaging of in situ nanoparticle movement and cellular behavior during neuroinflammationR35GM124677 · NIGMS · UNIVERSITY OF WASHINGTON · PI NANCE, ELIZABETH A · 2017 to 2022
$2.5M
NIGMS NIH HHS R35 GM124677
6 · The paper itself

Abstract

Predictive models of nanoparticle transport can drive design of nanotherapeutic platforms to overcome biological barriers and achieve localized delivery. In this paper, we demonstrate the ability of artificial neural networks to predict both nanoparticle properties, such as size and protein adsorption, and aspects of the brain microenvironment, such as cell internalization, viscosity, and brain region by using large (>100 000) trajectory datasets collected via multiple particle tracking in in vitro gel models of the brain and cultured organotypic brain slices. Our neural network achieved a 0.75 recall score when predicting gel viscosity based on trajectory datasets, compared to 0.49 using an obstruction scaling model. When predicting in situ nanoparticle size based on trajectory datasets, neural networks achieved a 0.90 recall score compared to 0.83 using an optimized Stokes-Einstein predictor. To distinguish between nanoparticles of different sizes in more complex nanoparticle mixtures, our neural network achieved up to a recall score of 0.85. Even in cases of more nuanced output variables where mathematical models are not available, such as protein adhesion, neural networks retained the ability to distinguish between particle populations (recall score of 0.89). These findings demonstrate how trajectory datasets in combination with machine learning techniques can be used to characterize the particle-microenvironment interaction space.

Identifiers

PMID31746912
PMCPMC7202937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.